The Role of Fibrinolytic System in Health and Disease
This is a review of the topic of fibrinolysis contributed by authors who are specialized in the clinical and basic studies of this topic. These include: the endothelial receptor of tissue plasminogen activator, by Dr. Katherine Hajjar; regulation of S100 by pml-rar-alpha oncoprotein, by Dr. O’Connel...
Saved in:
| Sonstige: | |
|---|---|
| Year of Publication: | 2022 |
| Language: | English |
| Physical Description: | 1 electronic resource (170 p.) |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 03483nam-a2200829z--4500 | ||
|---|---|---|---|
| 001 | 993545034304498 | ||
| 005 | 20231214133530.0 | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 202207s2022 xx |||||o ||| 0|eng d | ||
| 035 | |a (CKB)5690000000011957 | ||
| 035 | |a (oapen)https://directory.doabooks.org/handle/20.500.12854/87541 | ||
| 035 | |a (EXLCZ)995690000000011957 | ||
| 041 | 0 | |a eng | |
| 100 | 1 | |a Kwaan, Hau C. |4 edt | |
| 245 | 1 | 0 | |a The Role of Fibrinolytic System in Health and Disease |
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2022 | ||
| 300 | |a 1 electronic resource (170 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 520 | |a This is a review of the topic of fibrinolysis contributed by authors who are specialized in the clinical and basic studies of this topic. These include: the endothelial receptor of tissue plasminogen activator, by Dr. Katherine Hajjar; regulation of S100 by pml-rar-alpha oncoprotein, by Dr. O’Connell; receptor of urokinase type plasminogen activator, by Dr. M. Ploug et al.; tissue plasminogen activator induction in purjinjen neuron, by Dr. Seeds; fibrinolysis from the blood to the brain, by Dr. Robert Metcalf; tissue plasminogen activator induces the opening of the blood–brain barrier, by Dr. M. Yepes; fibrinolysis shutdown in trauma: a historical review and clinical application, by Drs. Hunter Moore and Ernest Moore; fibrinolysis in immunity, by Drs. K. Kolev and Robert Medcalf; the role of plasminogen activator inhibitor 1, by Drs. M. Erin, A.E. Boe, and E.A. Klyachko; and finally, persistent fibrinolysis shutdown is associated with increased mortality in severely injured trauma patients, by J.P. Meizoso. | ||
| 546 | |a English | ||
| 650 | 7 | |a Research & information: general |2 bicssc | |
| 650 | 7 | |a Biology, life sciences |2 bicssc | |
| 653 | |a COVID-19 | ||
| 653 | |a fibrinolysis | ||
| 653 | |a renin-aldosterone-angiotensin-system (RAAS) | ||
| 653 | |a plasminogen activator inhibitor 1 (PAI-1) | ||
| 653 | |a urokinase plasminogen activator | ||
| 653 | |a urokinase plasminogen activator receptor | ||
| 653 | |a plasminogen activator inhibitor-1 | ||
| 653 | |a acute lung injury and repair and pleural injury and pleural organization | ||
| 653 | |a PAI-1 | ||
| 653 | |a cardiovascular disease | ||
| 653 | |a cancer | ||
| 653 | |a inflammation | ||
| 653 | |a fibrosis | ||
| 653 | |a aging | ||
| 653 | |a obstructive sleep apnoea | ||
| 653 | |a OSA | ||
| 653 | |a coagulation | ||
| 653 | |a platelets | ||
| 653 | |a brown adipose tissue | ||
| 653 | |a obesity | ||
| 653 | |a plasminogen activation | ||
| 653 | |a immune response | ||
| 653 | |a thrombin activatable fibrinolysis inhibitor | ||
| 653 | |a TAFI | ||
| 653 | |a proCPU | ||
| 653 | |a proCPB | ||
| 653 | |a proCPR | ||
| 653 | |a carboxypeptidase | ||
| 653 | |a uPA | ||
| 653 | |a uPAR | ||
| 653 | |a PA system | ||
| 653 | |a tissue-type plasminogen activator (tPA) | ||
| 653 | |a urokinase-type plasminogen activator (uPA) | ||
| 653 | |a neurodegeneration | ||
| 653 | |a thrombin | ||
| 653 | |a shear | ||
| 653 | |a clot retraction | ||
| 653 | |a Factor XIII | ||
| 653 | |a clot stability | ||
| 653 | |a NETs | ||
| 653 | |a plasmin | ||
| 653 | |a plasminogen activator | ||
| 653 | |a PAI-2 | ||
| 653 | |a antiplasmin | ||
| 776 | |z 3-0365-4619-7 | ||
| 776 | |z 3-0365-4620-0 | ||
| 700 | 1 | |a Kwaan, Hau C. |4 oth | |
| 906 | |a BOOK | ||
| ADM | |b 2023-12-15 05:56:56 Europe/Vienna |f system |c marc21 |a 2022-07-14 08:50:39 Europe/Vienna |g false | ||
| AVE | |i DOAB Directory of Open Access Books |P DOAB Directory of Open Access Books |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337832870004498&Force_direct=true |Z 5337832870004498 |b Available |8 5337832870004498 | ||